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Abstract.  The origins of signaling by vertebrate steroids are not fully understood.  An important 
advance was the report that an estrogen-binding steroid receptor [SR] is present in amphioxus, a 
basal chordate with a similar body plan as vertebrates.  To investigate the evolution of estrogen 
binding to steroid receptors, we constructed a 3D model of amphioxus SR complexed with 
estradiol.  This 3D model indicates that although the SR is activated by estradiol, some 
interactions between estradiol and human ERα are not conserved in the SR, which can explain 
the low affinity of estradiol for the SR.  These differences between the SR and ERα in the 
steroid-binding domain are sufficient to suggest that another steroid is the physiological regulator 
of the SR.  The 3D model predicts that mutation of Glu-346 to Gln will increase the affinity of 
testosterone for amphioxus SR and elucidate the evolution of steroid binding to nuclear 
receptors. 
 
Introduction. 
Estradiol has diverse physiological actions in vertebrates [1-3], many of which are 
mediated by binding to the estrogen receptor [ER], a member of the nuclear receptor family, 
which is a large and diverse family of transcription factors [4-8].  This family also contains the 
androgen receptor (AR), glucocorticoid receptor (GR), mineralocorticoid receptor (MR) and 
progesterone receptor (PR) [4, 6-8]. 
Substantial progress in understanding the evolution of steroid receptors has come from 
deciphering their sequences in mammals, amphibians and fish.  An important advance was the 
cloning of the ER, corticoid receptor (CR), and PR from lamprey, a jawless fish at the base of the 
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vertebrate line [9].  Phylogenetic analysis of vertebrate steroid receptors shows that the ER is 
separate from the AR, PR, GR and MR [4, 6, 7, 9], which correlates with their steroid specificity.  
Endogenous estrogens have a phenolic A ring, while androgens, progestins, glucocorticoids and 
mineralocorticoids have a 3-keto-substituent in the A ring.  Phylogenetic analysis indicates that 
the ER is closest to the common ancestor of these adrenal and sex steroid receptors [9, 10]. 
Recently, two proteins with sequence similarity to steroid receptors were found in the 
amphioxus Branchiostoma floridae, which is a basal chordate with a similar body plan as 
vertebrates [11, 12].  Phylogenetic analyses place one of these receptors, amphioxus ER, as 
closest to vertebrate ERs, and the other receptor, amphioxus SR, as closest to the 3-ketosteroid 
receptors [13, 14].  A surprising finding is that amphioxus ER does not bind steroids [13, 14].  In 
contrast, amphioxus SR is activated by estradiol [13], although at an estradiol concentration that 
is more than 100-fold higher than found for binding to human ERα [15].  Unexpectedly, the SR 
does not bind 3-ketosteroids [13], despite the clear phylogenetic clustering of the SR with the 
GR, MR, PR and AR [13, 14]. 
To investigate the basis for these unexpected properties of amphioxus SR and to begin to 
understand early events in the evolution steroid receptors [4, 6, 7, 9, 13, 14, 16-18], we 
constructed a 3D model of amphioxus SR complexed with estradiol.  Our 3D model predicts a 
novel structure in the steroid-binding domain of the SR.  Some key interactions between 
estradiol and human ERα are conserved in amphioxus SR, which can explain the activation of 
SR by E2 and the lack of response to 3-ketosteroids.  However, other interactions between 
estradiol and human ERα are not conserved in amphioxus SR, which can explain the lower 
response to E2 of the SR compared to human ERα.  These differences in the steroid-binding site 
of amphioxous SR may mean that novel estradiol derivatives [19, 20] or other steroids [17, 21] 
are the physiological ligands for amphioxus SR.  Our 3D model of amphioxus SR predicts that 
mutation of Glu-346 to Gln will increase the affinity of testosterone for amphioxus SR and 
elucidate the evolution of steroid binding to nuclear receptors. 
Methods 
Construction of 3D Models  
The 3D structure of human ERα [PDB: 1G50] was used as a template for constructing 
the 3D model of amphioxus SR.  The aligned steroid-binding domain of amphioxus SR and 
human ERα are 32% identical and have 28% conservative replacements [e.g. arginine/lysine, 
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glutamic acid/aspartic acid], after addition of gaps [Figure 1].  We used the Multiple Mapping 
Method (MMM) software [22] to construct the 3D model of amphioxus SR.  Five alignment 
algorithms Muscle, Align2D, T-Coffee, ClustalW and ClustalW with modified gap penalty were 
used to align the target sequence, amphioxus SR [GenBank: ACB10649], with the human ERα 
template.  MMM took each alignment and constructed a composite alignment, which was used 
by Modeller [23] to construct a 3D model of amphioxus SR. 
We inserted E2 from human ERα into the apo-3D model of amphioxus SR after 
overlapping amphioxus SR with human ERα using the Biopolymer option in Insight II.  The 
structure of amphioxus SR with E2 was refined using Discover 3 in Insight II.  For this energy 
minimization step, Discover 3 was run for 10,000 iterations, using a distant dependent dielectric 
constant of 2. 
 
      |310      |320      |330      |340      |350      |360 
Amphioxus SR    301 YNPTVPLISHLVNIEPNPILTGYNPQCTPTEGYLMALVTDLANREIEGLVDWAARLPGYGMLPM 365 
Human ERα       309 SLTADQMVSALLDAEPPILYSEYDPTRPFSEASMMGLLTNLADRELVHMINWAKRVPGFVDLTL 372 
                  |310  |320      |330      |340      |350      |360      |370 
          α1                                α3 
 
 
       |370      |380      |390      |400      |410       |420 
Amphioxus SR    366 DDQVNLIRTVWLDLLMLGLVWRSMEHRGEWLVFAPDLLMDRSLCR-LSGMEYICTPMLEFARQF 428 
Human ERα       373 HDQVHLLECAWLEILMIGLVWRSMEHPGK-LLFAPNLLLDRNQGKCVEGMVEIFDMLLATSSRF 435 
                        |380      |390      |400       |410      |420      |430 
                       α4          α5             β1     β2     α6       α7  
 
    |430      |440      |450           |460      |470      |480 
Amphioxus SR    429 ADLQVPQEVYVCLKALTLYTTAV-----SRLQDYRQVQRLQHEINEALAEACSSTFGFSPGN-- 485 
Human ERα       436 RMMNLQGEEFVCLKSIILLNSGVYTFLSSTLKSLEEKDHIH-RVLDKITDTLIHLMAKAGLTLQ 498 
                     |440      |450      |460      |470       |480      |490       
               α8                               α9            
 
            |490      |500      |510      |520      |530       
Amphioxus SR    486 -----IARLMMIVSQVRQLSSLGVDHLNRLRGAETVSVEGLLREIVDEPPRITE 534 
Human ERα       499 QQHQRLAQLLLILSHIRHMSNKGMEHLYSMKCKNVVPLYDLLLEMLDAHRL--- 549 
                 |500      |510      |520      |530      |540       
           α10        α11              α12 
        __AF2_ 
 
_ Residues in Fig. 3 
_ Residues in Fig. 4  
_ Glu‐419, which stabilizes His‐524 
_ Residues that differ in amphioxus   
Figure 1.  Alignment of amphioxus SR with human ERα. 
α-helices and β-strands from the crystal structure of ERα [1G50] are shaded and notated below 
the alignment.  Residues in human ERα and amphioxus SR that have similar interactions with 
estradiol are shown in green and analyzed in Figure 3.  Residues in amphioxus SR and ERα that 
differ in binding estradiol are shown in yellow and analyzed in Figure 4.  Residues in amphioxus 
SR that differ from that human ERα are shown in red.  The conserved Glu-419 is shown in 
brown. 
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Results 
Figure 2 shows that there is excellent overlap, especially in the estrogen-binding pocket, 
of our 3D model of amphioxus SR and the crystal structure of human ERα.  The root mean 
square deviation [RMSD] of their Cα chains is 1.7 Å. 
 
 
Figure 2.  Overlap of human ERα with the 3D model of amphioxus SR . 
The 3D model of amphioxus SR was superimposed on human ERα.  There is excellent overlap.  
The root mean square deviation between their Cα backbones is 1.7A. 
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Similarities between estradiol binding to human ERα and amphioxus SR. 
In Figures 3A and 3B, we show the interaction of E2 with key residues that stabilize E2 
in human ERα [24-26] and amphioxus SR, respectively.  Figure 3A shows the hydrogen bonds 
between E2 and Glu-353 and Arg-394 on human ERα.  The phenolic hydroxyl on E2 is 2.8 Å 
from Oε2 on Glu-353 and 2.9 Å from Nη2 on Arg-394.  Nε on Arg-394 contacts the backbone 
oxygen on Phe-404.  Cε2 on Phe-404 also has a van der Waals contact with C10 on estradiol.  
Cδ1 on Leu-525 and Cε on Met-421 have van der Waals contacts with the 17β-hydroxyl and 
C16, respectively, on E2 [Figure 3A].   
 
Figure 3. Similarities in the binding of estradiol to human ERα and amphioxus SR. 
A. Interaction between estradiol and human ERα. 
B. Interaction between estradiol and the 3D model of amphioxus SR. 
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Figure 3B shows that in amphioxus SR the C3-hydroxyl on E2 is 2.7 Å from Oε1 on Glu-
346 and 3.5 Å from Nη1 on Arg-387.  Nε on Arg-387 is 4 Å from the backbone oxygen on Phe-
398.  Cε2 on Phe-389 has a van der Waals contact with C10 on E2.  Cβ on Leu-507 and Sδ on 
Met-414 have van der Waals contacts with 17β-hydroxyl and C16, respectively, on E2 [Figure 
3B].  The backbone oxygen of Gly-503 contacts the 17β-hydroxyl of E2. 
Differences between estradiol binding to human ERα and amphioxus SR. 
There are, however, several differences between human ERα and amphioxus SR in their 
interaction with E2.  Figure 4 shows the residues on human ERα and amphioxus SR that we find 
differ in binding E2. 
 
Figure 4.  Differences the binding of estradiol to human ERα and amphioxus SR. 
A. Interaction between estradiol and human ERα. 
B. Interaction between estradiol and the 3D model of amphioxus SR. 
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In human ERα, Nδ1 on His-524 is 2.8 Å from the 17β-hydroxyl on the D ring of E2.  In 
addition, Cε1 on His-524 has a van der Waals contact with the 17β-hydroxyl on E2, which is 3.4 
Å from Cε1 [not shown].  His-524 also is stabilized by an interaction with the backbone oxygen 
on Glu-419, which is 3.3 Å from Nε2 on His-524 [25] [Figure 4A].  E2 has stabilizing contacts 
with Sδ of Met-343 and Cδ1 on Ile-424 [Figure 4A]. 
In amphioxus SR, due to a rotation of His-506, it has a different interaction with the 17β-
hydroxyl on E2.  Nδ1 on His-506 is 3.2 Å from the 17β-hydroxyl on E2 [Figure 3B].  Cε1 on 
His-506 does not have a van der Waals contact with the 17β-hydroxyl on E2.  However, Cδ2 on 
His-506 has van der Waal contacts with the 17β-hydroxyl, C17 and C16 on E2, which are 3.6 Å, 
3.9 Å and 3.5 Å distant, respectively, from Cδ2 [not shown]. 
In amphioxus SR, Met-336, which corresponds to Met-343 on human ERα, does not 
have a stabilizing contact with E2.  Instead, Sδ on Met-336 is 7.2 Å from the 17β-hydroxyl on 
E2.  The backbone nitrogen of Ser-412 is 3.4 Å from Nε2 on His-506.  Ile-417 does not interact 
with E2 [Figure 4B]. 
 
Discussion 
Two recent studies with amphioxus ER and SR have provided important insights into the 
ancestry of steroid receptor signaling in chordates [13, 14].  The absence of E2 activation of 
amphioxus ER [13, 14] and the activation by E2 of amphioxus SR [13] were surprising.  In a cell 
culture assay, amphioxus SR is not as responsive to E2 as is human ERα; the SR requires about 
100 nM E2 to activate gene transcription to 50% of the maximum response [13].  This is 
substantially higher than 0.2 nM E2 for the Kd of E2 for human ERα [15]. 
Unexpectedly, amphioxus SR is not activated by 3-ketosteroids [13], although the SR 
sequence clearly clusters in a phylogenetic analysis with 3-ketosteroid receptors  [13, 14].  These 
intriguing findings indicate that there are unique aspects of amphioxus SR regarding steroid 
binding [13].  Our 3D model of amphioxus SR begins to elucidate some of its surprising 
properties. 
Comparisons of the 3D structures of human ERα and amphioxus SR reveal that their 
overall 3D structures are conserved.  Indeed, amphioxus SR contains key residues that are 
important for stabilizing binding of E2 to human ERα [Figure 3B] [13].  In particular, Glu-346 
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and Arg-387 stabilize the C3-hydroxyl on E2.  Moreover, His-506 has a stabilizing contact with 
the 17β-hydroxyl on E2.  This interaction between histidine and E2 is unique to vertebrate ERs 
and is not found in other adrenal and sex steroid receptors [27-31] including the lamprey PR and 
CR [9].  Also stabilizing E2 in amphioxus SR are contacts between the 17β-hydroxyl on E2 and 
Gly-503 and Leu-507 [Figure 3B]. 
There are differences in the binding of the D ring to the SR, which may contribute to the 
lower transcriptional activation of amphioxus SR by E2.  Compared to His-524 in human ERα, 
His-506 has rotated and does not have the same stabilizing interactions with E2 as found in 
human ERα.  Also in amphioxus SR, Met-336 and Ile-417 do not contact E2 [Figure 4B]. 
Evolutionary implications 
Amphioxus SR is intriguing because, although it binds and is activated by E2 [13], the 
amino acid sequence of SR clearly places it closest to the GR and other 3-ketosteroid receptors 
[13, 14].  Moreover, the SR does not bind 3-ketosteroids.  This may be due to the presence of 
Glu-346 instead of a Gln, which acts as a hydrogen bond donor to the C3-ketone in the PR [31], 
GR [27], AR [30] and MR [28, 29].  Indeed, Ekena et al. [32] showed that in human ERα, 
conversion of Glu-353 to Gln increases the affinity of mutant human ERα for testosterone by 
140-fold, providing a parsimonious mechanism for the evolution of receptors that respond to 3-
ketosteroids from an ER. 
E2 and the enzymes that can synthesize E2 are found in amphioxus [33, 34].  However, 
physiological regulation of amphioxus SR activity by 100 nM E2 is unlikely because the E2 
concentration in amphioxus is low [34].  It may be that the SR is activated by an estradiol 
derivative [19, 20]or other steroids, such as Δ5-androstene-3β,17β-diol [Δ5-Adiol] and 5-
androstane-3β,17β-diol [17, 21].  Both Δ5-Adiol and 5-androstane-3β,17β-diol have Kds in the 
nM range for human ERα [15], and both steroids contain a C3 alcohol and a 17β-hydroxyl that 
can form a hydrogen bond with Glu-346 and His-506, respectively, in amphioxus SR. 
Δ5-Adiol, which is formed from DHEA by reduction of the C17-ketone to an alcohol can 
be metabolized to testosterone by 3β-hydroxysteroid dehydrogenase.  Testosterone would be an 
inactive metabolite.  However, mutation of Glu-346 to Gln in the SR may yield a mutant receptor 
that binds testosterone [32], providing a mechanism for the evolution of receptors for 3-
ketosteroids.  This hypothesis can be tested by investigating the steroid specificity of the Gln-346 
mutant. 
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